Role of SOCS2 in modulating heart damage and function in a murine model of acute Chagas disease.
Esper, Lisia; Roman-Campos, Danilo; Lara, Aline; Brant, Fatima; Castro, Luisa L; Barroso, Andreia; Araujo, Ronan Ricardo S; Vieira, Leda Q; Mukherjee, Shankar; Gomes, Eneas Ricardo M; Rocha, Nazareth N; Ramos, Isalira P R; Lisanti, Michael P; Campos, Camila F; Arantes, Rosa M E; Guatimosim, Silvia; Weiss, Louis M; Cruz, Jader Santos; Tanowitz, Herbert B; Teixeira, Mauro M; Machado, Fabiana S.
Am J Pathol
; 181(1): 130-40, 2012 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-22658486
Autoimmune pathogenesis of Chagas heart disease: looking back, looking ahead.
Nucleotide and nucleoside involvement in immunomodulation in experimental Chagas disease.
Investigation of the role of IL17A gene variants in Chagas disease.
Towards a paradigm shift in the treatment of chronic Chagas disease.
Combined analysis of cross-reacting antibodies anti-ß1AR and anti-B13 in advanced stages of Chagas heart disease.
Vaccine-Linked Chemotherapy Improves Benznidazole Efficacy for Acute Chagas Disease.
Trypanosoma cruzi burden, genotypes, and clinical evaluation of Chilean patients with chronic Chagas cardiopathy.
Chagas disease cardiomyopathy: immunopathology and genetics.
Expression and production of cardiac angiogenic mediators depend on the Trypanosoma cruzi-genetic population in experimental C57BL/6 mice infection.
Trypanosoma cruzi strains in the Calomys callosus: parasitemia and reaction of intracellular forms with stage-specific antibodies in the acute and chronic phase of infection and after immunosuppression.